Pathogenesis of Penile Squamous Cell Carcinoma: Molecular Update and Systematic Review.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
27 Dec 2021
Historique:
received: 30 11 2021
revised: 22 12 2021
accepted: 23 12 2021
entrez: 11 1 2022
pubmed: 12 1 2022
medline: 2 2 2022
Statut: epublish

Résumé

Penile squamous cell carcinoma (PSCC) is a rare but aggressive neoplasm with dual pathogenesis (human papillomavirus (HPV)-associated and HPV-independent). The development of targeted treatment is hindered by poor knowledge of the molecular landscape of PSCC. We performed a thorough review of genetic alterations of PSCC focused on somatic mutations and/or copy number alterations. A total of seven articles have been identified which, overall, include 268 PSCC. However, the series are heterogeneous regarding methodologies employed for DNA sequencing and HPV detection together with HPV prevalence, and include, in general, a limited number of cases, which results in markedly different findings. Reported top-ranked mutations involve

Identifiants

pubmed: 35008677
pii: ijms23010251
doi: 10.3390/ijms23010251
pmc: PMC8745288
pii:
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Références

Int J Mol Sci. 2021 Jun 30;22(13):
pubmed: 34209172
Oncotarget. 2018 Mar 23;9(22):16074-16086
pubmed: 29662627
Oncol Res. 2016;23(1-2):13-20
pubmed: 26802646
Transl Androl Urol. 2017 Oct;6(5):791-802
pubmed: 29184775
Dtsch Arztebl Int. 2018 Sep 28;115(39):646-652
pubmed: 30375327
Curr Opin Otolaryngol Head Neck Surg. 2017 Apr;25(2):108-112
pubmed: 28141601
Mol Oncol. 2016 Aug;10(7):1008-29
pubmed: 27118659
Oncotarget. 2017 Feb 28;8(9):15294-15306
pubmed: 28122331
Am J Surg Pathol. 2010 Mar;34(3):385-92
pubmed: 20139761
Genes Chromosomes Cancer. 2015 Oct;54(10):629-37
pubmed: 26216163
Chin J Cancer. 2011 Jan;30(1):5-12
pubmed: 21192840
Int J Cancer. 2019 Sep 1;145(5):1280-1289
pubmed: 31034097
World J Urol. 2021 May;39(5):1405-1411
pubmed: 33145666
Eur Urol. 2016 May;69(5):953-61
pubmed: 26762611
Oncoscience. 2015 Apr 28;2(4):320-33
pubmed: 26097867
Front Oncol. 2020 Dec 14;10:596261
pubmed: 33381457
Oncogene. 2006 Sep 28;25(44):5985-93
pubmed: 16682952
Cells. 2020 Dec 12;9(12):
pubmed: 33322834
Virchows Arch. 2019 Oct;475(4):397-405
pubmed: 31243533
Am J Surg Pathol. 2011 Apr;35(4):553-62
pubmed: 21399489
Ann Transl Med. 2020 Jul;8(13):813
pubmed: 32793658
Oncol Lett. 2021 May;21(5):398
pubmed: 33777221
Clin Cancer Res. 2021 May 1;27(9):2560-2570
pubmed: 33441293
Cancer Res. 2016 Aug 15;76(16):4720-4727
pubmed: 27325650
Oncol Ther. 2021 Jun;9(1):21-39
pubmed: 33454930
Nat Genet. 2013 Oct;45(10):1127-33
pubmed: 24071851
Eur Urol. 2016 Jul;70(1):93-105
pubmed: 26935559
Eur Urol Focus. 2019 Sep;5(5):713-717
pubmed: 31288989
Am J Surg Pathol. 2011 Feb;35(2):253-61
pubmed: 21263246
Cancer Res. 2015 Dec 15;75(24):5219-27
pubmed: 26670561
Clin Cancer Res. 2021 May 1;27(9):2375-2377
pubmed: 33653819
Mol Carcinog. 2020 Jun;59(6):604-617
pubmed: 32212199
J Urol. 2019 Mar;201(3):541-548
pubmed: 30291913
Rev Panam Salud Publica. 2017 Nov 30;41:e117
pubmed: 31384255
Urol Clin North Am. 2010 Aug;37(3):335-42
pubmed: 20674690
Oncotarget. 2014 Apr 30;5(8):2000-15
pubmed: 24899581
BioDrugs. 2019 Oct;33(5):539-553
pubmed: 31392631
Cancer Prev Res (Phila). 2015 Feb;8(2):149-56
pubmed: 25502573

Auteurs

Inmaculada Ribera-Cortada (I)

Department of Pathology, Hospital Clínic of Barcelona, University of Barcelona, 08036 Barcelona, Spain.

José Guerrero-Pineda (J)

Department of Pathology, Hospital Clínic of Barcelona, University of Barcelona, 08036 Barcelona, Spain.

Isabel Trias (I)

Department of Pathology, Hospital Clínic of Barcelona, University of Barcelona, 08036 Barcelona, Spain.

Luis Veloza (L)

Institute of Pathology, Lausanne University Hospital, Lausanne University, 1011 Lausanne, Switzerland.

Adriana Garcia (A)

Department of Pathology, Hospital Clínic of Barcelona, University of Barcelona, 08036 Barcelona, Spain.

Lorena Marimon (L)

Department of Pathology, Hospital Clínic of Barcelona, University of Barcelona, 08036 Barcelona, Spain.
Barcelona Institute for Global Health (ISGlobal), Hospital Clínic-Universitat de Barcelona, 08036 Barcelona, Spain.

Sherley Diaz-Mercedes (S)

Department of Pathology, Hospital Clínic of Barcelona, University of Barcelona, 08036 Barcelona, Spain.

José Ramon Alamo (JR)

Department of Pathology, Hospital Clínic of Barcelona, University of Barcelona, 08036 Barcelona, Spain.

Maria Teresa Rodrigo-Calvo (MT)

Department of Pathology, Hospital Clínic of Barcelona, University of Barcelona, 08036 Barcelona, Spain.

Naiara Vega (N)

Department of Pathology, Hospital Clínic of Barcelona, University of Barcelona, 08036 Barcelona, Spain.

Ricardo López Del Campo (R)

Department of Pathology, Hospital Clínic of Barcelona, University of Barcelona, 08036 Barcelona, Spain.

Rafael Parra-Medina (R)

Department of Pathology, Research Institute, Fundación Universitaria de Ciencias de la Salud, Bogota 111221, Colombia.

Tarek Ajami (T)

Uro-Oncology Unit, Hospital Clínic of Barcelona, University of Barcelona, 08036 Barcelona, Spain.

Antonio Martínez (A)

Department of Pathology, Hospital Clínic of Barcelona, University of Barcelona, 08036 Barcelona, Spain.
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain.

Oscar Reig (O)

Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain.
Institute of Hematologic and Oncologic Diseases, Hospital Clínic of Barcelona, University of Barcelona, 08036 Barcelona, Spain.

Maria J Ribal (MJ)

Uro-Oncology Unit, Hospital Clínic of Barcelona, University of Barcelona, 08036 Barcelona, Spain.
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain.

Juan Manuel Corral-Molina (JM)

Uro-Oncology Unit, Hospital Clínic of Barcelona, University of Barcelona, 08036 Barcelona, Spain.

Pedro Jares (P)

Department of Pathology, Hospital Clínic of Barcelona, University of Barcelona, 08036 Barcelona, Spain.
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain.

Jaume Ordi (J)

Department of Pathology, Hospital Clínic of Barcelona, University of Barcelona, 08036 Barcelona, Spain.
Barcelona Institute for Global Health (ISGlobal), Hospital Clínic-Universitat de Barcelona, 08036 Barcelona, Spain.

Natalia Rakislova (N)

Department of Pathology, Hospital Clínic of Barcelona, University of Barcelona, 08036 Barcelona, Spain.
Barcelona Institute for Global Health (ISGlobal), Hospital Clínic-Universitat de Barcelona, 08036 Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH